Innoplexus, a global artificial intelligence (AI) company founded in 2015, has a recently published application for assessing the value of drug discovery research.
A research project or document is assessed using two factors, status and association. These two factors are derived from the researchers and field of the current drug discovery research when compared against any previous research with a potential connection. Ultimately, an assessment value, in cryptocurrency, is created for future transactions relating to the specific drug discovery research.
In addition, this procedure also serves as an authentication process, as it provides an insight into the credibility of a particular research group.
This is Innoplexus' fifth patent application in the cryptocurrency sector, with the remaining four focusing more on blockchain-related technologies.
